Pregnant women with a history of illicit drug or controlled prescription medication use, along with women having psychiatric diagnoses, are found to be at high risk for drug abuse during pregnancy. Maternal drug use during pregnancy can have profoundly adverse developmental effects on the fetus; including neurological development, physical development and stillbirths.
Proper treatment and management can be established for women who are pregnant and abusing drugs once the drugs of abuse are been identified.
Discovering prescription or illicit drug abuse early in a pregnancy is critical to managing the overall wellbeing of the fetus.
Babies who are exposed to opioids, methadone, buprenorphine or heroin in utero are at risk for being born with Neonatal Abstinence Syndrome (NAS). Complications for a newborn associated with NAS includes, premature birth, low birth weight, seizures, respiratory diagnoses, and feeding difficulties. Mean hospital charges for a newborn diagnosed with NAS can range from $60,000 to over $90,000 dependent upon the course of treatment; while the average cost for uncomplicated term infants is $3,500. Incidence and prevalence of NAS has increased rapidly over the past decade.
Detecting Drug Use During Pregnancy Protects the Fetus, Mother, and Provider
American College of Obstetrics and Gynecologists (ACOG) recommends universal screening for all maternal substance use.
Why screen for drug use during pregnancy?
Outcomes associated with drug use during pregnancy
Alcohol and Tobacco still pose greatest risks to fetus
ACOG recommends increased focus on curbing alcohol and tobacco use during pregnancy
30 Day Account Integration – LabSource Quickly Communicates Issues That Can Affect Testing and Turn-Around Time.
Solid Phase Extraction & Concentrate Eliminates Interferences and Extracts Drugs to Increase Sensitivity. Evaporates Liquid Leaving High Concentrations of Drugs for Maximum Sensitivity.
Patient Results are Compared to the Patient’s Previous Results.
Automatic Re-test and Verification of Unexpected Results; We Re-test 10% of Specimens.
Ask About Our Clinical Toxicology Testing Services